237 related articles for article (PubMed ID: 33817981)
1. Dosimetric feasibility of stereotactic ablative radiotherapy in pulmonary vein isolation for atrial fibrillation using intensity-modulated proton therapy.
Ren XY; He PK; Gao XS; Zhao ZL; Zhao B; Bai Y; Liu SW; Li K; Qin SB; Ma MW; Zhou J; Rong Y
J Appl Clin Med Phys; 2021 May; 22(5):79-88. PubMed ID: 33817981
[TBL] [Abstract][Full Text] [Related]
2. [Dosimetric comparison of the helical tomotherapy, intensity-modulated radiotherapy and volumetric-modulated arc therapy in radical radiotherapy for esophageal cancer].
Xu YJ; Li P; Hu X; Wang J; Ma HL; Chen M
Zhonghua Yi Xue Za Zhi; 2019 Nov; 99(41):3260-3265. PubMed ID: 31694123
[No Abstract] [Full Text] [Related]
3. Small-spot intensity-modulated proton therapy and volumetric-modulated arc therapies for patients with locally advanced non-small-cell lung cancer: A dosimetric comparative study.
Liu C; Sio TT; Deng W; Shan J; Daniels TB; Rule WG; Lara PR; Korte SM; Shen J; Ding X; Schild SE; Bues M; Liu W
J Appl Clin Med Phys; 2018 Nov; 19(6):140-148. PubMed ID: 30328674
[TBL] [Abstract][Full Text] [Related]
4. Volumetric modulated arc therapy versus intensity-modulated proton therapy in neoadjuvant irradiation of locally advanced oesophageal cancer.
Celik E; Baus W; Baues C; Schröder W; Clivio A; Fogliata A; Scorsetti M; Marnitz S; Cozzi L
Radiat Oncol; 2020 May; 15(1):120. PubMed ID: 32448296
[TBL] [Abstract][Full Text] [Related]
5. Intensity-modulated proton therapy decreases dose to organs at risk in low-grade glioma patients: results of a multicentric in silico ROCOCO trial.
Eekers DBP; Roelofs E; Cubillos-Mesías M; Niël C; Smeenk RJ; Hoeben A; Minken AWH; Granzier M; Janssens GO; Kaanders JHAM; Lambin P; Troost EGC
Acta Oncol; 2019 Jan; 58(1):57-65. PubMed ID: 30474448
[TBL] [Abstract][Full Text] [Related]
6. Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate cases.
Tran A; Zhang J; Woods K; Yu V; Nguyen D; Gustafson G; Rosen L; Sheng K
Radiat Oncol; 2017 Jan; 12(1):10. PubMed ID: 28077128
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric Comparison of Helical Tomotherapy, Volumetric-Modulated Arc Therapy, and Intensity-Modulated Proton Therapy for Angiosarcoma of the Scalp.
Mizuno T; Tomita N; Takaoka T; Tomida M; Fukuma H; Tsuchiya T; Shibamoto Y
Technol Cancer Res Treat; 2021; 20():1533033820985866. PubMed ID: 33517860
[TBL] [Abstract][Full Text] [Related]
8. Training and validation of a knowledge-based dose-volume histogram predictive model in the optimisation of intensity-modulated proton and volumetric modulated arc photon plans for pleural mesothelioma patients.
Franceschini D; Cozzi L; Fogliata A; Marini B; Di Cristina L; Dominici L; Spoto R; Franzese C; Navarria P; Comito T; Reggiori G; Tomatis S; Scorsetti M
Radiat Oncol; 2022 Aug; 17(1):150. PubMed ID: 36028862
[TBL] [Abstract][Full Text] [Related]
9. Towards the clinical implementation of intensity-modulated proton therapy for thoracic indications with moderate motion: Robust optimised plan evaluation by means of patient and machine specific information.
Ribeiro CO; Visser S; Korevaar EW; Sijtsema NM; Anakotta RM; Dieters M; Both S; Langendijk JA; Wijsman R; Muijs CT; Meijers A; Knopf A
Radiother Oncol; 2021 Apr; 157():210-218. PubMed ID: 33545257
[TBL] [Abstract][Full Text] [Related]
10. Dose-volume comparison of intensity modulated proton therapy and volumetric modulated arc therapy for cervical esophageal cancer.
Kato T; Ono T; Narita Y; Komori S; Murakami M
Med Dosim; 2022 Autumn; 47(3):216-221. PubMed ID: 35346554
[TBL] [Abstract][Full Text] [Related]
11. Tomotherapy as a neoadjuvant treatment for locally advanced esophageal cancer might increase bone marrow toxicity in comparison with intensity-modulated radiotherapy and volumetric-modulated arc therapy.
Wang Y; Xiao Q; Zeng B; Ni Q; Liu X; Liu X; Tian L; Sheng C; Peng L; Wang H
Med Dosim; 2020 Spring; 45(1):e6-e12. PubMed ID: 31176536
[TBL] [Abstract][Full Text] [Related]
12. The Potential Role of Intensity-Modulated Proton Therapy in Hepatic Carcinoma in Mitigating the Risk of Dose De-Escalation.
Cozzi L; Comito T; Loi M; Fogliata A; Franzese C; Franceschini D; Clerici E; Reggiori G; Tomatis S; Scorsetti M
Technol Cancer Res Treat; 2020; 19():1533033820980412. PubMed ID: 33287650
[TBL] [Abstract][Full Text] [Related]
13. Volumetric modulated arc therapy versus intensity-modulated proton therapy in the postoperative irradiation of thymoma.
Franceschini D; Cozzi L; Loi M; Franzese C; Reggiori G; Mancosu P; Clivio A; Fogliata A; Scorsetti M
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2267-2276. PubMed ID: 32514629
[TBL] [Abstract][Full Text] [Related]
14. Comparison of photon volumetric modulated arc therapy, intensity-modulated proton therapy, and intensity-modulated carbon ion therapy for delivery of hypo-fractionated thoracic radiotherapy.
Chi A; Lin LC; Wen S; Yan H; Hsi WC
Radiat Oncol; 2017 Aug; 12(1):132. PubMed ID: 28810881
[TBL] [Abstract][Full Text] [Related]
15. Which technique for radiation is most beneficial for patients with locally advanced cervical cancer? Intensity modulated proton therapy versus intensity modulated photon treatment, helical tomotherapy and volumetric arc therapy for primary radiation - an intraindividual comparison.
Marnitz S; Wlodarczyk W; Neumann O; Koehler C; Weihrauch M; Budach V; Cozzi L
Radiat Oncol; 2015 Apr; 10():91. PubMed ID: 25896675
[TBL] [Abstract][Full Text] [Related]
16. Organ sparing potential and inter-fraction robustness of adaptive intensity modulated proton therapy for lung cancer.
van der Laan HP; Anakotta RM; Korevaar EW; Dieters M; Ubbels JF; Wijsman R; Sijtsema NM; Both S; Langendijk JA; Muijs CT; Knopf AC
Acta Oncol; 2019 Dec; 58(12):1775-1782. PubMed ID: 31556764
[No Abstract] [Full Text] [Related]
17. Heart and Cardiac Substructure Dose Sparing in Synchronous Bilateral Breast Radiotherapy: A Dosimetric Study of Proton and Photon Radiation Therapy.
Sun T; Lin X; Tong Y; Liu X; Pan L; Tao C; Duan J; Yin Y
Front Oncol; 2019; 9():1456. PubMed ID: 31998635
[No Abstract] [Full Text] [Related]
18. Dosimetric and radiobiological impact of intensity modulated proton therapy and RapidArc planning for high-risk prostate cancer with seminal vesicles.
Rana S; Cheng C; Zhao L; Park S; Larson G; Vargas C; Dunn M; Zheng Y
J Med Radiat Sci; 2017 Mar; 64(1):18-24. PubMed ID: 27741379
[TBL] [Abstract][Full Text] [Related]
19. Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin's lymphoma. Assessment of risk of toxicity and secondary cancer induction.
Scorsetti M; Cozzi L; Navarria P; Fogliata A; Rossi A; Franceschini D; De Rose F; Franzese C; Carlo-Stella C; Santoro A
Radiat Oncol; 2020 Jan; 15(1):12. PubMed ID: 31931861
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric Comparison of Helical Tomotherapy and Intensity-Modulated Proton Therapy in Hippocampus- and Scalp-Sparing Whole Brain Radiotherapy.
Takaoka T; Tomita N; Mizuno T; Hashimoto S; Tsuchiya T; Tomida M; Yanagi T
Technol Cancer Res Treat; 2021; 20():15330338211060170. PubMed ID: 34806489
[No Abstract] [Full Text] [Related]
[Next] [New Search]
